| |
 |
Board of Trustees
WILLIAM WOOD ALLEN
Chief Executive Officer
WoodAllen Capital Management, LLC
PETER S. AMENTA, M.D., Ph.D.*
Dean
UMDNJ-Robert Wood Johnson
Medical School
SUBHA V. BARRY - Chair
THOMAS A. BRACKEN
President
TriState Capital Bank
ROBERT E. CAMPBELL
Chair, CINJ Advisory Council
Johnson & Johnson, Vice Chairman (Retired)
ROBERT S. DiPAOLA, M.D.*
Director
The Cancer Institute of New Jersey
Professor of Medicine
UMDNJ, Robert Wood Johnson Medical School
JEFFREY N. EDWARDS
Partner
New Vernon Capital, LLC
AUDREY GOULD
Senior Vice President
The Gould Group of Wachovia Securities
WILLIAM N. HAIT, M.D., Ph.D.
Senior Vice President
Worldwide Head of Hematology/Oncology
Research and Development
Johnson & Johnson Pharmaceutical Research and Development, LLC
RONALD J. LEVINE, Esq.
Partner
Herrick, Feinstein, LLP, Newark, NJ
DUNCAN L. MacMILLAN
Co-Founder
Bloomberg LP
PAUL MIGNON
President and Chief Operating Officer
Ventiv Pharma Teams
inVentiv Commercial Services
MICHELLE MORTON
President and Chief Executive Officer
Pacific American Securities, LLC
DENISE V. RODGERS, MD
Executive Vice President for Academic and Clinical Affairs
University of Medicine and Dentistry of New Jersey
RICHARD C. ROSENZWEIG, Esq.
Associate General Counsel
C.R. Bard, Inc.
LESLIE LOGAN TAYLOR
Partner
Matrix Development Group
JOHN R. WHITMAN
Managing Partner
Sycamore Management Corporation
SUSAN WOLFORD
Managing Director and Sector Head
BMO Capital Markets Business Services & Media Group
ARSHAD R. ZAKARIA
President and Chief Executive Officer
New Vernon Capital, LLC
*Ex-Officio
|
|
|
